NCT04720417 2025-07-15Defactinib and VS-6766 for the Treatment of Patients With Metastatic Uveal MelanomaThomas Jefferson UniversityPhase 2 Terminated13 enrolled 13 charts
NCT03999515 2023-09-28Erdafitinib and Abiraterone Acetate or Enzalutamide in Treating Patients With Double Negative Prostate CancerUniversity of WashingtonPhase 2 Terminated3 enrolled 9 charts